Skip to main content

Table 5 Haplotype distribution in the stroke and control groups

From: Association of ALOX5APgene single nucleotide polymorphisms and cerebral infarction in the Han population of northern China

Public Name

Haplotype

Control Groups (n = 219)

Case Groups (n = 236)

OR (95% CI)

P

rs4147064 & rs9579646

CCAA

36 (17%)

26 (11%)

Ref

--

  

CCAG

50 (23%)

40 (17%)

1.11 (0.58-2.13)

0.759

  

CCGG

11 (5%)

19 (8%)

2.39 (0.98-5.87)

0.057

  

CTAA

15 (7%)

20 (8%)

1.85 (0.80-4.27)

0.152

  

CTAG

53 (24%)

64 (27%)

1.67 (0.90-3.12)

0.105

  

CTGG

26 (12%)

32 (14%)

1.70 (0.83-3.51)

0.148

  

TTAA

4 (2%)

0 (0%)

--

--

  

TTAG

13 (6%)

18 (8%)

1.92 (0.80-4.59)

0.144

  

TTGG

10 (5%)

17 (7%)

2.35 (0.93-5.97)

0.071

rs4073259 & rs10507391

AAAT

6 (3%)

2 (1%)

Ref

--

  

AATT

39 (18%)

64 (27%)

4.92 (0.95-25.61)

0.058

  

AGAA

2 (1%)

3 (1%)

4.50 (0.41-49.63)

0.219

  

AGAT

75 (34%)

90 (38%)

3.60 (0.71-18.36)

0.123

  

AGTT

40 (18%)

30 (13%)

2.25 (0.42-11.94)

0.341

  

GGAA

29 (13%)

25 (11%)

2.59 (0.48-13.98)

0.27

  

GGAT

24 (11%)

20 (8%)

2.50 (0.45-13.78)

0.293

  

GGTT

3 (1%)

2 (1%)

2.00 (0.18-22.06)

0.571

rs9315050 & rs9551963

AAAA

99 (45%)

84 (36%)

Ref

--

  

AAAC

85 (39%)

110 (47%)

1.53 (1.02-2.29)

0.041*

  

AACC

26 (12%)

34 (14%)

1.54 (0.86-2.77)

0.149

  

AGAC

6 (3)%

6 (3%)

1.18 (0.37-3.79)

0.783

  

AGCC

2 (1%)

2 (1%)

1.18 (0.16-8.55)

0.871

  1. Data are presented as numbers (percentages) or odds ratios (OR) with 95% confidence interval (CI).
  2. *Significant differences between control and case groups (P < 0.05).